CRISPR-Based Genetic Improvement of Aquaculture Species
Fishes,
Год журнала:
2025,
Номер
10(2), С. 84 - 84
Опубликована: Фев. 18, 2025
The
clustered
regularly
interspaced
short
palindromic
repeat-associated
protein
(CRISPR-Cas)
system
is
considered
a
potential
game-changer
in
the
aquaculture
sector.
CRISPR-Cas9
derived
from
an
adaptive
mechanism
of
immune
some
prokaryotes.
CRISPR/Cas9
potentially
accelerates
rate
sustained
genetic
gain
for
and
seafood
production
sectors.
Unlike
conventional
genome-editing
techniques,
more
cost-effective,
user-friendly,
extremely
precise.
It
enables
overcoming
large-scale
challenges
aquaculture.
Traits
such
as
high
fertility,
external
fertilization,
shorter
generation
time,
well-established
breeding
methods,
ability
to
raise
larvae
offer
benefits
applying
genome
editing
most
aquacultural
species.
use
precise
where
desired
modifications
are
made
target
gene.
There
likelihood
that
intended
alterations
will
be
achieved,
resulting
transmission
trait
next
generation.
In
this
paper,
we
review
how
CRISPR
evolved,
its
basic
categories
different
Cas
systems,
well
molecular
CRISPR/Cas.
We
also
highlight
discuss
applications
CRISPR/Cas
industry.
Moreover,
using
technology
briefly
discussed.
This
pathway
charts
course
future
which
has
enable
fulfill
world
food
requirements
with
public
ecological
safety.
Язык: Английский
CRISPR RNA-Guided Gene Editing and its Clinical Research Applications in Hematology with Focus on Inherited Germline Predisposition to Hematologic Malignancies
Опубликована: Июнь 10, 2024
Clustered
regularly
interspaced
short
palindromic
repeats
(CRISPR)
based
gene-editing
has
begun
to
transform
the
treatment
landscape
of
genetic
diseases.
The
history
discovery
CRISPR/CRISPR-associated
(Cas)
proteins/single
guide
RNA
(sgRNA)-based
since
first
report
repetitive
sequences
unknown
significance
in
1987
is
fascinating,
instructive,
and
inspiring
for
future
advances.
recent
approval
CRISPR-Cas9-based
gene
therapy
treat
patients
with
severe
sickle
cell
anemia
transfusion-dependent
beta
thalassemia
renewed
hope
treating
other
hematologic
diseases,
including
germline
predisposition
malignancies,
who
would
benefit
greatly
from
development
CRISPR-based
therapies.
purpose
this
manuscript
three-fold:
first,
a
chronological
description
CRISPR-Cas9-sgRNA-based
editing;
second,
brief
current
state
clinical
research
selected
applications
diseases
therapy;
third,
progress
therapies
inherited
bone
marrow
failure
syndromes,
hopefully
stimulate
efforts
towards
developing
these
syndromes
conditions
malignancies.
Язык: Английский